The reseller agreement provides a potential revenue stream from UK NHS adoption, but without disclosed minimums or upfront cash, the near-term financial impact is unquantifiable. Given the going concern warning from prior filings, traders should monitor for any revenue recognition under this deal and for further liquidity events.
Price Chart
Executive Summary
Nano-X Imaging subsidiary Nanox AI signed a three-year exclusive sales reseller agreement with Vertec Scientific Ltd. to commercialize HealthOST (its AI bone health software) in the UK, where NICE has recommended the solution for NHS use. The deal includes minimum annual license commitments but no upfront or guaranteed dollar amounts are disclosed, and the company recently disclosed substantial doubt about its ability to continue as a going concern.
Key Facts
- Exclusive three-year reseller agreement with Vertec Scientific for HealthOST in the UK.
- HealthOST is FDA-cleared and UKCA/CE-marked; NICE recommended it for NHS use in November 2025.
- Agreement includes minimum annual license commitments; no dollar figures disclosed.
- Nano-X previously disclosed substantial doubt about its ability to continue as a going concern in its August 7 offering filing.
Financial Impact
Undisclosed minimum annual license commitments; no revenue or deal value stated.
Risk Factors
- No disclosed deal value or minimum commitment amounts — revenue impact speculative.
- Company recently raised $7.6M and disclosed substantial doubt about going concern; liquidity risk remains acute.
- UK NHS adoption timelines and HealthOST market penetration may be slow.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3346800 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 16, 2026 10d ago | 6-K | $0.4100 | awaiting T+20 | — | $0.3430 (+16.34%) |
Oct 16, 2026 10d ago | Press Release | $0.4100 | awaiting T+20 | — | $0.3430 (+16.34%) |
Oct 2, 2026 24d ago | 6-K | $0.6430 | awaiting T+20 | — | $0.3430 (+46.66%) |
Sep 9, 2026 6w ago | 6-K | $0.7800 $0.5950 | ▲ +23.72% | ▲ +25.66% | $0.3430 (+56.03%) |
Aug 18, 2026 9w ago | Press Release | $0.8869 $0.7537 | ▼ −15.02% | ▼ −13.27% | $0.3430 (−61.33%) |
Aug 18, 2026 9w ago | 6-K | $0.8869 $0.7537 | ▲ +15.02% | ▲ +13.27% | $0.3430 (+61.33%) |
Aug 7, 2026 11w ago | 424B5 | $1.06 $0.8298 | ▲ +21.72% | ▲ +21.32% | $0.3430 (+67.64%) |
Aug 4, 2026 11w ago | 144 | $1.07 $0.7859 | ▼ −26.55% | ▼ −25.31% | $0.3430 (−67.94%) |
Jul 28, 2026 12w ago | 144 | $0.8772 $0.8758 | ▲ +0.16% | ▲ +5.18% | $0.3430 (+60.90%) |
Jul 23, 2026 13w ago | 6-K | $0.8962 $0.8599 | ▲ +4.05% | ▲ +7.68% | $0.3430 (+61.73%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers